Q&A - Koite Health's answers to investors' questions
1. How will Koite Health monitor and evaluate the long-term impact of Lumoral on patients' oral health?
The therapeutic effects of Koite Health's treatment are being monitored in more than 15 ongoing clinical trials, with the longest treatment period now lasting six months. At six months, Lumoral treatment achieved healthy gums in 76% of chronic gingivitis patients compared to only about 30% of patients with the current best treatment. The six-month treatment results were therefore excellent. In addition to this, we are also collecting feedback from our customers who have reported cleaner teeth and less tartar build-up. We are closely monitoring patient feedback and experiences in our research and aftermarket monitoring, which will be used in the further development of the product.
2. Does the company have any plans to collaborate with dental chains or clinics?
We have already started collaborating with several dental clinics and chains. In Finland, Lumoral is usually recommended by dentists and sold through pharmacies/net shops, but several dentists have already sold dozens of units to clinics. Our partner clinics include Aqua Dental and Södertandläkarna in Sweden and in Finland Kotihammas, Kruunu Hammasklinikka, Hygga, Smilespa, Miunpaikka, Zahnaslääkärikeskus Jouheva, and several dentists at Oral and Mehiläinen dental clinics recommend Lumoral to their patients. Internationally, our partners in Germany have trained over 30% of all German oral hygienists, in Italy our partner is a highly respected dental implant provider and in Denmark our partner is a specialist dental surgery equipment distributor with a desire to bring Lumoral into local specialist dental care.
3. Does the company have any plans to collaborate with other oral health technology companies? Are there plans to partner with insurance companies?
We are also actively discussing with global dental companies and looking for collaboration opportunities, especially in the area of treatment monitoring and measuring treatment outcomes. We have already established excellent relationships with key players in this field. We have already been in discussions with several insurance companies and these discussions will progress further as more information from our ongoing studies becomes available, allowing for cost calculations of treatment effects.
4. Is it possible to publish Koite Health's September sales performance to support the investment decision?
Monthly sales vary by a few tens of thousands depending on the month in which retailer orders fall. Monthly sales for September were €113,000 and cumulative sales for 01-09/2023 reached €986,695. We expect Q4 to be the best in Koite Health Ltd's history and to reach our €1 500 000 turnover target for this year. The end of the year is historically good for Lumoral and Koite Health and our partners are investing heavily in increasing sales of the product in Europe.
Webinar recording and Q&A - Koite Health's answers to investors' questions
1. How does the method target only harmful bacteria?
With Lumoral, Lumorinse mouth rinse is mainly attached to the dental plaque and the Lumoral light applicator is used to direct the light onto the tooth surface. The antibacterial effect is thus focused on the tooth surface and the gum line where bacteria that cause dental disease can develop. Healthy bacteria elsewhere in the mouth do not receive antibacterial treatment and thus maintain the normal bacterial balance in the mouth.
2. What is the revenue stream from Lumorinse tablets?
The revenue stream from tablet sales was already €23,000 in August and is growing strongly as the Lumoral user base expands.
3. Is it possible that someone else will start selling tablets or a similar product at a lower price?
It is very difficult to bring a Lumoral-compatible mouthwash to the market because the product has to be clinically proven and registered as a medical device. Lumoral is protected by patents and trademarks, which prevents a competitor from bringing a clinically equivalent product to market. Lumoral and Lumorinse trademark protection also prevents a competitor from mentioning Lumoral and Lumorinse in their product and marketing.
4. Dental caries (tooth decay) is a disease caused by microbial dysbiosis, like periodontitis, and globally even more common than periodontitis. You say that Lumoral also has beneficial effects in the treatment of caries. Is there any research data to support this claim?
Lumoral treatment is highly effective against the caries-causing bacteria Streptococcus mutans. This antibacterial efficacy has been verified by thousands of bacteriological tests and the results have been published in the peer-reviewed scientific journal Plos One. In clinical trials, we have also found that Lumoral treatment reduces the amount of dental plaque and the amount of cariogenic bacteria present in dental plaque.
Q&A - Koite Health's answers to investors' questions
1. Does Lumoral or the mouth rinse Lumorinse attack tooth enamel or does it rather strengthen it?
Lumoral mouth rinse does not attack or damage the enamel. Lumoral protects the enamel by removing acid-producing bacteria from the surface of the enamel. Acid-producing bacteria are the main contributors of tooth decay which is why Lumoral is so good for in preventing tooth decay development.
2. What are the ingredients of the Lumorinse mouth rinse? Does it contain fluoride?
Mannitol, xylitol, ascorbic acid, sodium bicarbonate, polyvidone, indocyanine green, magnesium stearate, silicon dioxide, peppermint aroma. The key ingredient is the Indocyanine green which a harmless color used widely in medical diagnostics and treatments.
3. How are sales currently distributed among the different countries?
In the first 8 months of 2023, Finland and Sweden accounted for 81.5% of Lumoral sales. The new markets and distribution agreements which were signed in during the spring (Germany, Italy, UK, Denmark) are now starting to kick in and in August the European sales accounted already for 32% of sales.
4. On lumoral.com there is talk of whitening - is this like bleaching or in any way harmful to teeth, enamel etc.? If not, why or what would be the difference to whitening by bleaching?
Lumoral's whitening effect is based on removing staining and coloring from the surface of the teeth. This is based on the enhanced removal of dental plaque (bacteria) from the surface of the teeth. This effect is beneficial for teeth, enamel and gums.
5. Are Lumoral's patents such that competitors cannot produce a similar product?
Lumoral is protected by several patents. Two patents protect the Lumoral product and method itself, two other patents protect the future development solutions of the Lumoral device, and two other patents protect the expansion of Lumoral technology to new indications of use, such as the treatment of skin bacterial infections.